Bereich
Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen
ENDO · Dept. I
[Craniopharyngioma--a "geographical malignant" tumour]
Stienen M, Cadosch D, Bilz S, Hildebrandt G, Gautschi O. [Craniopharyngioma--a "geographical malignant" tumour]. Praxis (Bern 1994) 2010; 99:911-21.
28.07.2010[Craniopharyngioma--a "geographical malignant" tumour]
28.07.2010Praxis (Bern 1994) 2010; 99:911-21
Stienen Martin N., Cadosch D, Bilz Stefan, Hildebrandt Gerhard, Gautschi Oliver
Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
Steffen T, Warschkow R, Brändle M, Tarantino I, Clerici T. Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery. Br J Surg 2010; 97:1000-6.
01.07.2010Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery
01.07.2010Br J Surg 2010; 97:1000-6
Steffen Thomas, Warschkow Rene, Brändle Michael, Tarantino Ignazio, Clerici Thomas
Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population
Fontaine-Bisson B, Renström F, Rolandsson O, Payne F, Hallmans G, Barroso I, Franks P. Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population. Diabetologia 2010; 53:2155-62.
23.06.2010Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population
23.06.2010Diabetologia 2010; 53:2155-62
Fontaine-Bisson B, Renström Frida, Rolandsson O, Payne F, Hallmans G, Barroso I, Franks P W
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Böhm S, Hess D, Gillessen Sommer S, Brändle M. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care 2010; 33:e82.
01.06.2010Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
01.06.2010Diabetes care 2010; 33:e82
Böhm Steffen, Hess Dagmar, Gillessen Sommer Silke, Brändle Michael
Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients
Drescher T, Singler K, Ulrich A, Koller M, Keller U, Christ-Crain M, Kressig R. Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients. Eur J Clin Nutr 2010; 64:887-93.
19.05.2010Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients
19.05.2010Eur J Clin Nutr 2010; 64:887-93
Drescher Tilman, Singler K, Ulrich A, Koller M, Keller U, Christ-Crain M, Kressig R W
Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance
Viardot A, Sze L, Purtell L, Sainsbury A, Loughnan G, Smith E, Herzog H, Steinbeck K, Campbell L. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab 2010; 95:3392-9.
05.05.2010Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance
05.05.2010J Clin Endocrinol Metab 2010; 95:3392-9
Viardot Alexander, Sze Lisa, Purtell Louise, Sainsbury Amanda, Loughnan Georgina, Smith Ellie, Herzog Herbert, Steinbeck Katharine, Campbell Lesley V
Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry
Gradmark A, Rydh A, Renström F, De Lucia-Rolfe E, Sleigh A, Nordström P, Brage S, Franks P. Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry. Br J Nutr 2010; 104:582-8.
07.04.2010Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry
07.04.2010Br J Nutr 2010; 104:582-8
Gradmark Anna M I, Rydh Anders, Renström Frida, De Lucia-Rolfe Emanuella, Sleigh Alison, Nordström Peter, Brage Soren, Franks Paul W
Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
Krull I, Maier M, Bärlocher K, Koehler K, Huebner A, Brändle M. Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome. Exp Clin Endocrinol Diabetes 2010; 118:530-6.
03.03.2010Two patients with an identical novel mutation in the AAAS gene and similar phenotype of triple A (Allgrove) syndrome
03.03.2010Exp Clin Endocrinol Diabetes 2010; 118:530-6
Krull Ina, Maier Margarete, Bärlocher K, Koehler K, Huebner A, Brändle Michael
Hyponatremia associated coma due to pituitary apoplexy in early pregnancy: a case report
Krull I, Christ E, Kamm C, Ganter C, Sahli R. Hyponatremia associated coma due to pituitary apoplexy in early pregnancy: a case report. Gynecol Endocrinol 2010; 26:197-200.
01.03.2010Hyponatremia associated coma due to pituitary apoplexy in early pregnancy: a case report
01.03.2010Gynecol Endocrinol 2010; 26:197-200
Krull Ina, Christ Emanuel, Kamm Christian Philipp, Ganter Christoph, Sahli Rahel
Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
Brändle M. Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie - Contra - eine kritische Beurteilung. Swiss Medical Forum 2010; 10:88-91.
04.02.2010Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
04.02.2010Swiss Medical Forum 2010; 10:88-91
Brändle Michael
Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus
Schimke K, Davis T. Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus. Expert Review of Clinical Pharmacology 2009; 1:13-25.
04.12.2009Inhaled human insulin (Exubera®): its pharmacologic profile, efficacy and safety in the treatment of adults with diabetes mellitus
04.12.2009Expert Review of Clinical Pharmacology 2009; 1:13-25
Schimke Katrin-Elisabeth, Davis Timothy Marc Earls
Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
Schimke K, Greminger P, Brändle M. Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51.
01.11.2009Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
01.11.2009Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51
Schimke Katrin-Elisabeth, Greminger Peter, Brändle Michael
Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Christ E, Maecke H, Martius F, Gloor B, Clerici T, Sahli R, Brändle M, Forrer F, Wild D, Reubi J. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. The Journal of clinical endocrinology and metabolism 2009; 94:4398-405.
01.11.2009Glucagon-like peptide-1 receptor imaging for localization of insulinomas
01.11.2009The Journal of clinical endocrinology and metabolism 2009; 94:4398-405
Christ Emanuel, Maecke Helmut, Martius Ferdinand, Gloor Beat, Clerici Thomas, Sahli Rahel, Brändle Michael, Forrer Flavio, Wild Damian, Reubi Jean Claude
[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
Lehmann R, Troendle A, Brändle M, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie. [New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]. Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706.
01.10.2009[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
01.10.2009Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706
Lehmann Roger, Troendle A, Brändle Michael, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie
Factors in serum from type 2 diabetes patients can cause cellular insulin resistance
Renström F, Burén J, Svensson M, Eriksson J. Factors in serum from type 2 diabetes patients can cause cellular insulin resistance. Horm Metab Res 2009; 41:767-72.
01.10.2009Factors in serum from type 2 diabetes patients can cause cellular insulin resistance
01.10.2009Horm Metab Res 2009; 41:767-72
Renström Frida, Burén J, Svensson M K, Eriksson J W
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Cathomas R, Köberle D, Ruhstaller T, Mayer G, Räss A, Mey U, von Moos R. Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
12.09.2009Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
12.09.2009Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
Cathomas Richard, Köberle Dieter, Ruhstaller Thomas, Mayer Gisela, Räss Andrea, Mey Ulrich, von Moos Roger
Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays
Krull I. Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays. Diabetic Medicine 2009; 2009 Oct;26(10):1075-6:1075-1076.
04.08.2009Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays
04.08.2009Diabetic Medicine 2009; 2009 Oct;26(10):1075-6:1075-1076
Krull Ina
Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
Brändle M, Erny-Albrecht K, Goodall G, Spinas G, Streit P, Valentine W. Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland. International journal of clinical pharmacology and therapeutics 2009; 47:501-15.
01.08.2009Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
01.08.2009International journal of clinical pharmacology and therapeutics 2009; 47:501-15
Brändle Michael, Erny-Albrecht K M, Goodall G, Spinas G A, Streit P, Valentine W J
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution
Morris A, Stringham H, Swift A, Tuomi T, Uda M, Vollenweider P, Waeber G, Wallace C, Walters G, Weedon M, Witteman J, Zhang C, Zhang W, Caulfield M, Collins F, Davey Smith G, Yuan X, Song K, Munroe P, Narisu N, Nordström A, Nordström P, Oostra B, Palmer C, Payne F, Peden J, Prokopenko I, Renström F, Ruokonen A, Salomaa V, Sandhu M, Scott L, Scuteri A, Silander K, Day I, Franks P, Hugh Watkins, Waterworth D, Boehnke M, Deloukas P, Groop L, Hunter D, Thorsteinsdottir U, Schlessinger D, Wichmann H, Frayling T, Abecasis G, Hirschhorn J, Loos R, Stefansson K, Mohlke K, Barroso I, Wareham N, van Duijn C, Hattersley A, Hu F, Jarvelin M, Kong A, Kooner J, Laakso M, Lakatta E, Mooser V, Morris A, Peltonen L, Samani N, Spector T, Strachan D, Tanaka T, Tuomilehto J, Uitterlinden A, McCarthy M, Lindgren C, Lyon H, Rivadeneira F, Sanna S, Timpson N, Zillikens M, Zhao J, Almgren P, Bandinelli S, Bennett A, Bergman R, Bonnycastle L, Bumpstead S, Chanock S, Cherkas L, Chines P, Coin L, Luan J, Drong A, Heid I, Randall J, Lamina C, Steinthorsdottir V, Qi L, Speliotes E, Thorleifsson G, Willer C, Herrera B, Jackson A, Lim N, Scheet P, Soranzo N, Amin N, Aulchenko Y, Chambers J, Cooper C, Crawford G, Hofman A, Holle R, Holloway J, Illig T, Isomaa B, Jacobs L, Jameson K, Jousilahti P, Karpe F, Kuusisto J, Laitinen J, Lathrop G, Lawlor D, Mangino M, McArdle W, Meitinger T, Havulinna A, Hamsten A, Doering A, Dominiczak A, Doney A, Ebrahim S, Elliott P, Erdos M, Estrada K, Ferrucci L, Fischer G, Forouhi N, Gieger C, Grallert H, Groves C, Grundy S, Guiducci C, Hadley D, Morken M. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009; 5:e1000508.
26.06.2009Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution
26.06.2009PLoS Genet 2009; 5:e1000508
Morris Andrew P, Stringham Heather M, Swift Amy J, Tuomi Tiinamaija, Uda Manuela, Vollenweider Peter, Waeber Gerard, Wallace Chris, Walters G Bragi, Weedon Michael N, Witteman Jacqueline C M, Zhang Cuilin, Zhang Weihua, Caulfield Mark J, Collins Francis S, Davey Smith George, Yuan Xin, Song Kijoung, Munroe Patricia, Narisu Narisu, Nordström Anna, Nordström Peter, Oostra Ben A, Palmer Colin N A, Payne Felicity, Peden John F, Prokopenko Inga, Renström Frida, Ruokonen Aimo, Salomaa Veikko, Sandhu Manjinder S, Scott Laura J, Scuteri Angelo, Silander Kaisa, Day Ian N M, Franks Paul W, Hugh Watkins, Waterworth Dawn M, Boehnke Michael, Deloukas Panos, Groop Leif, Hunter David J, Thorsteinsdottir Unnur, Schlessinger David, Wichmann H-Erich, Frayling Timothy M, Abecasis Gonçalo R, Hirschhorn Joel N, Loos Ruth J F, Stefansson Kari, Mohlke Karen L, Barroso Inês, Wareham Nicholas J, van Duijn Cornelia M, Hattersley Andrew T, Hu Frank B, Jarvelin Marjo-Riitta, Kong Augustine, Kooner Jaspal S, Laakso Markku, Lakatta Edward, Mooser Vincent, Morris Andrew D, Peltonen Leena, Samani Nilesh J, Spector Timothy D, Strachan David P, Tanaka Toshiko, Tuomilehto Jaakko, Uitterlinden André G, McCarthy Mark I, Lindgren Cecilia M, Lyon Helen N, Rivadeneira Fernando, Sanna Serena, Timpson Nicholas J, Zillikens M Carola, Zhao Jing Hua, Almgren Peter, Bandinelli Stefania, Bennett Amanda J, Bergman Richard N, Bonnycastle Lori L, Bumpstead Suzannah J, Chanock Stephen J, Cherkas Lynn, Chines Peter, Coin Lachlan, Luan Jian'an, Drong Alexander, Heid Iris M, Randall Joshua C, Lamina Claudia, Steinthorsdottir Valgerdur, Qi Lu, Speliotes Elizabeth K, Thorleifsson Gudmar, Willer Cristen J, Herrera Blanca M, Jackson Anne U, Lim Noha, Scheet Paul, Soranzo Nicole, Amin Najaf, Aulchenko Yurii S, Chambers John C, Cooper Cyrus, Crawford Gabriel, Hofman Albert, Holle Rolf, Holloway John W, Illig Thomas, Isomaa Bo, Jacobs Leonie C, Jameson Karen, Jousilahti Pekka, Karpe Fredrik, Kuusisto Johanna, Laitinen Jaana, Lathrop G Mark, Lawlor Debbie A, Mangino Massimo, McArdle Wendy L, Meitinger Thomas, Havulinna Aki S, Hamsten Anders, Doering Angela, Dominiczak Anna, Doney Alex S F, Ebrahim Shah, Elliott Paul, Erdos Michael R, Estrada Karol, Ferrucci Luigi, Fischer Guido, Forouhi Nita G, Gieger Christian, Grallert Harald, Groves Christopher J, Grundy Scott, Guiducci Candace, Hadley David, Morken Mario A
Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
Goede D, Wiesli P, Brändle M, Bestmann L, Bernays R, Zwimpfer C, Schmid C. Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44.
13.06.2009Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
13.06.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44
Goede Diane L, Wiesli Peter, Brändle Michael, Bestmann Lukas, Bernays René L, Zwimpfer Cornelia, Schmid Christoph